Phillips-Medisize beefs up capabilities in Europe and U.S.

08/11/2012

Phillips-Medisize is increasing manufacturing capabilities in the United States and Europe to meet growing demand in the medical market, particularly for easier-to-use drug delivery systems and minimally invasive surgical components.

A plant in the Czech republic was expanded by 10,000 sq ft to provide more cleanroom production space and expand its capabilities, which include plastic and liquid silicone rubber (LSR) injection molding, catheter extrusion, and assembly capabilities in class 7 and 8 cleanrooms.

The facility is FDA registered and ISO13485 certified and uses the global Phillips-Medisize quality system.

"Our Czech facility is an important part of our strategy of providing state-of-the-art medical facilities, equipped with the latest technologies, to our customers in regions around the world," said Matt Jennings, President and CEO of Phillips-Medisize Corp.